Arcutis Biotherapeutics, Inc.
US ˙ NasdaqGS ˙ US03969K1088

SecurityARQT / Arcutis Biotherapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in ARQT / Arcutis Biotherapeutics, Inc.

On May 14, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Arcutis Biotherapeutics, Inc. (US:ARQT) valued at $0 USD as of March 31, 2025. The entity filed a previous 13F-HR/A on May 14, 2025 disclosing 5,338 shares of Arcutis Biotherapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ARQT) in the form of stock options. The firm currently holds call options representing 138,700 of underlying shares valued at $4,027,848 USD and put options representing 4,500 of underlying shares valued at $130,680 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARQT / Arcutis Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-14 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 0 -5,338 -100.00 0 -100.00
2025-05-14 2024-12-31 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 5,338 5,338 74 0.0002
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 5,338 5,338 74 0.0002
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 0 -60,347 -100.00 0 -100.00
2024-05-10 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 60,347 8,661 16.76 598 260.24 0.0023
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 51,686 51,686 167 0.0004
2023-11-09 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 0 -3,379 -100.00 0 -100.00
2023-08-09 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 3,379 3,379 32 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 138,700 38.42 4,028 113.29 n/a n/a n/a
2025-11-12 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 100,200 -57.12 1,889 -42.37 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 233,700 0.09 3,276 -10.27 n/a n/a n/a
2025-05-14 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 233,500 665.57 3,652 761.08 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARCUTIS BIOTHERAPEUTICS COM Call 30,500 -62.90 425 -44.50 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 30,500 425 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 82,200 -61.08 764 -61.10 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 211,200 179.74 1,964 162.57 n/a n/a n/a
2024-05-10 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 75,500 -31.92 748 108.94 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 110,900 1,748.33 358 1,054.84 n/a n/a n/a
2023-11-09 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 6,000 1,100.00 32 675.00 n/a n/a n/a
2023-08-09 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 500 -97.54 5 -98.21 n/a n/a n/a
2023-05-12 2023-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 20,300 -81.79 223 -86.48 n/a n/a n/a
2023-02-09 2022-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 111,500 24.72 1,650 -3.40 n/a n/a n/a
2022-11-09 2022-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 89,400 1,708 n/a n/a n/a
2022-08-11 2022-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 4,700 91 n/a n/a n/a
2022-02-11 2021-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2021-11-12 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 32,200 2,583.33 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 1,200 -69.23 33 -70.80 n/a n/a n/a
2021-05-12 2021-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 3,900 113 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 4,500 -48.28 131 -20.25 n/a n/a n/a
2025-11-12 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 8,700 24.29 164 66.33 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 7,000 -5.41 98 -14.78 n/a n/a n/a
2025-05-14 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 7,400 -86.67 116 -85.12 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARCUTIS BIOTHERAPEUTICS COM Put 55,500 285.42 773 481.20 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 55,500 773 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 14,400 -21.31 134 -21.76 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 18,300 -78.19 170 -79.54 n/a n/a n/a
2024-05-10 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 83,900 49.29 831 359.12 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 56,200 5,520.00 182 3,520.00 n/a n/a n/a
2023-11-09 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 1,000 -93.33 5 -96.48 n/a n/a n/a
2023-08-09 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 15,000 143 n/a n/a n/a
2021-11-12 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 100 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.